Kiniksa Pharmaceuticals International, plc KNSA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's free cash flow?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported free cash flow of $50.04M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's free cash flow changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's free cash flow increased by 125.1% year-over-year, from $22.23M to $50.04M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's free cash flow?
- Over 3 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's free cash flow has grown at a 2.5% compound annual growth rate (CAGR), from -$126.71M to $136.42M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.